TY - JOUR
T1 - Emergency Department Visits by Children With Congenital Heart Disease
AU - Edelson, Jonathan B.
AU - Rossano, Joseph W.
AU - Griffis, Heather
AU - Dai, Dingwei
AU - Faerber, Jennifer
AU - Ravishankar, Chitra
AU - Mascio, Christopher E.
AU - Mercer-Rosa, Laura M.
AU - Glatz, Andrew C.
AU - Lin, Kimberly Y.
N1 - Funding Information:
Dr. Rossano has served as a consultant for Novartis and Amgen. Dr. Mascio has served as a consultant to and received honoraria from HeartWare. Dr. Mercer-Rosa has received support from National Institutes of Health grant NIH K01HL125521, and from the Pulmonary Hypertension Society. Dr. Lin has served as a consultant for Pfizer. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Publisher Copyright:
© 2018 American College of Cardiology Foundation
PY - 2018/10/9
Y1 - 2018/10/9
N2 - Background: Data related to the epidemiology and resource utilization of congenital heart disease (CHD)–related emergency department (ED) visits in the pediatric population is limited. Objectives: The purpose of this analysis was to describe national estimates of pediatric CHD-related ED visits and evaluate medical complexity, admissions, resource utilization, and mortality. Methods: This was an epidemiological analysis of ED visit-level data from the 2006 to 2014 Nationwide Emergency Department Sample. Patients age <18 years with CHD were identified using International Classification of Diseases-9th Revision-Clinical Modification codes. We evaluated time trends using weighted regression and tested the hypothesis that medical complexity, resource utilization, and mortality are higher in CHD patients. Results: A total of 420,452 CHD-related ED visits (95% confidence interval [CI]: 416,897 to 422,443 visits) were identified, accounting for 0.17% of all pediatric ED visits. Those with CHD were more likely to be <1 year of age (43% vs. 13%), and to have ≥1 complex chronic condition (35% vs. 2%). CHD-related ED visits had higher rates of inpatient admission (46% vs. 4%; adjusted odds ratio: 1.89; 95% CI: 1.85 to 1.93), higher median ED charges ($1,266 [interquartile range (IQR): $701 to $2,093] vs. $741 [IQR: $401 to $1,332]), and a higher mortality rate (1% vs. 0.04%; adjusted odds ratio: 1.25; 95% CI: 1.07 to 1.45). Adjusted median charges for CHD-related ED visits increased from $1,219 (IQR: $673 to $2,138) to $1,630 (IQR: $901 to $2,799), while the mortality rate decreased from 1.13% (95% CI: 0.71% to 1.52%) to 0.75% (95% CI: 0.41% to 1.09%) over the 9 years studied. Conclusions: Children with CHD presenting to the ED represent a medically complex population at increased risk for morbidity, mortality, and resource utilization compared with those without CHD. Over 9 years, charges increased, but the mortality rate improved.
AB - Background: Data related to the epidemiology and resource utilization of congenital heart disease (CHD)–related emergency department (ED) visits in the pediatric population is limited. Objectives: The purpose of this analysis was to describe national estimates of pediatric CHD-related ED visits and evaluate medical complexity, admissions, resource utilization, and mortality. Methods: This was an epidemiological analysis of ED visit-level data from the 2006 to 2014 Nationwide Emergency Department Sample. Patients age <18 years with CHD were identified using International Classification of Diseases-9th Revision-Clinical Modification codes. We evaluated time trends using weighted regression and tested the hypothesis that medical complexity, resource utilization, and mortality are higher in CHD patients. Results: A total of 420,452 CHD-related ED visits (95% confidence interval [CI]: 416,897 to 422,443 visits) were identified, accounting for 0.17% of all pediatric ED visits. Those with CHD were more likely to be <1 year of age (43% vs. 13%), and to have ≥1 complex chronic condition (35% vs. 2%). CHD-related ED visits had higher rates of inpatient admission (46% vs. 4%; adjusted odds ratio: 1.89; 95% CI: 1.85 to 1.93), higher median ED charges ($1,266 [interquartile range (IQR): $701 to $2,093] vs. $741 [IQR: $401 to $1,332]), and a higher mortality rate (1% vs. 0.04%; adjusted odds ratio: 1.25; 95% CI: 1.07 to 1.45). Adjusted median charges for CHD-related ED visits increased from $1,219 (IQR: $673 to $2,138) to $1,630 (IQR: $901 to $2,799), while the mortality rate decreased from 1.13% (95% CI: 0.71% to 1.52%) to 0.75% (95% CI: 0.41% to 1.09%) over the 9 years studied. Conclusions: Children with CHD presenting to the ED represent a medically complex population at increased risk for morbidity, mortality, and resource utilization compared with those without CHD. Over 9 years, charges increased, but the mortality rate improved.
KW - congenital heart diseases
KW - emergency department visit
KW - mortality
KW - resource utilization
UR - http://www.scopus.com/inward/record.url?scp=85053841101&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2018.07.055
DO - 10.1016/j.jacc.2018.07.055
M3 - Article
C2 - 30286926
AN - SCOPUS:85053841101
SN - 0735-1097
VL - 72
SP - 1817
EP - 1825
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 15
ER -